112 related articles for article (PubMed ID: 29276861)
1. Low Circulating Levels of Neurotensin in Women with Nonalcoholic Fatty Liver Disease Associated with Severe Obesity.
Auguet T; Aragonès G; Berlanga A; Martínez S; Sabench F; Aguilar C; Villar B; Sirvent JJ; Del Castillo D; Richart C
Obesity (Silver Spring); 2018 Feb; 26(2):274-278. PubMed ID: 29276861
[TBL] [Abstract][Full Text] [Related]
2. Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism.
Villar B; Bertran L; Aguilar C; Binetti J; Martínez S; Sabench F; Real M; Riesco D; París M; Del Castillo D; Richart C; Auguet T
Metabolites; 2021 Jun; 11(6):. PubMed ID: 34200577
[TBL] [Abstract][Full Text] [Related]
3. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis.
Auguet T; Bertran L; Binetti J; Aguilar C; Martínez S; Sabench F; Lopez-Dupla JM; Porras JA; Riesco D; Del Castillo D; Richart C
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545403
[TBL] [Abstract][Full Text] [Related]
4. Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Aragonès G; Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Armengol S; Sabench F; Ras R; Hernandez M; Aguilar C; Colom J; Sirvent JJ; Del Castillo D; Richart C
PLoS One; 2016; 11(4):e0154601. PubMed ID: 27123846
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity.
Bertran L; Portillo-Carrasquer M; Aguilar C; Porras JA; Riesco D; Martínez S; Vives M; Sabench F; Gonzalez E; Del Castillo D; Richart C; Auguet T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34198988
[TBL] [Abstract][Full Text] [Related]
6. Circulating microbiota-derived metabolites: a "liquid biopsy?
Aragonès G; Colom-Pellicer M; Aguilar C; Guiu-Jurado E; Martínez S; Sabench F; Antonio Porras J; Riesco D; Del Castillo D; Richart C; Auguet T
Int J Obes (Lond); 2020 Apr; 44(4):875-885. PubMed ID: 31388096
[TBL] [Abstract][Full Text] [Related]
7. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.
Auguet T; Aragonès G; Berlanga A; Guiu-Jurado E; Martí A; Martínez S; Sabench F; Hernández M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669236
[TBL] [Abstract][Full Text] [Related]
8. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
9. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
[TBL] [Abstract][Full Text] [Related]
10. Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.
Ma DW; Arendt BM; Hillyer LM; Fung SK; McGilvray I; Guindi M; Allard JP
Nutr Diabetes; 2016 Jul; 6(7):e220. PubMed ID: 27428872
[TBL] [Abstract][Full Text] [Related]
11. Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes.
Barchetta I; Cimini FA; Leonetti F; Capoccia D; Di Cristofano C; Silecchia G; Orho-Melander M; Melander O; Cavallo MG
J Clin Endocrinol Metab; 2018 Jun; 103(6):2253-2260. PubMed ID: 29590379
[TBL] [Abstract][Full Text] [Related]
12. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
[TBL] [Abstract][Full Text] [Related]
13. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women.
Terra X; Auguet T; Broch M; Sabench F; Hernández M; Pastor RM; Quesada IM; Luna A; Aguilar C; del Castillo D; Richart C
Obesity (Silver Spring); 2013 Jan; 21(1):170-7. PubMed ID: 23505183
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin in morbidly obese women with non-alcoholic fatty liver disease.
Auguet T; Aragonès G; Berlanga A; Martínez S; Sabench F; Binetti J; Aguilar C; Porras JA; Molina A; Del Castillo D; Richart C
PLoS One; 2017; 12(10):e0187065. PubMed ID: 29065180
[TBL] [Abstract][Full Text] [Related]
15. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
16. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Porras JA; Aragonès G; Sabench F; Hernandez M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2014 Dec; 15(12):22173-87. PubMed ID: 25474087
[TBL] [Abstract][Full Text] [Related]
17. The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease.
Bertran L; Pastor A; Portillo-Carrasquer M; Binetti J; Aguilar C; Martínez S; Vives M; Sabench F; Porras JA; Riesco D; Del Castillo D; Richart C; Auguet T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063472
[TBL] [Abstract][Full Text] [Related]
18. Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD.
Binetti J; Bertran L; Riesco D; Aguilar C; Martínez S; Sabench F; Porras JA; Camaron J; Castillo DD; Richart C; Auguet T
Life (Basel); 2020 Oct; 10(10):. PubMed ID: 33081272
[TBL] [Abstract][Full Text] [Related]
19. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
20. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
